# Citicholine-Amantadine Trial in Traumatic Brain Injury

> **NCT03430817** · PHASE4 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 45 (actual)

## Conditions studied

- Intensive Care Unit

## Interventions

- **DRUG:** Citicholine
- **DRUG:** Amantadine

## Key facts

- **NCT ID:** NCT03430817
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-07
- **Primary completion:** 2024-03-24
- **Final completion:** 2024-04-20
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2024-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03430817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03430817, "Citicholine-Amantadine Trial in Traumatic Brain Injury". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03430817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*